Gilman Law LLP Announces FDA Advisory Panel’s Recommendation To Change Labeling On Yaz and Yasmin Bi
Women Who Suffered Blood Clots After Using Yaz, Yasmin or Ocella Birth Control Pills May be Entitled to File Lawsuits to Recover Damages for Their Injuries Naples, Fl (PRWEB) December 22, 2011 Gilman Law announces that on December 8, 2011, the U.S. Food and Drug Administration (FDA) advisory committee voted 21-5 that the labeling on Yaz, Yasmin and other similar birth control pills is inadequate and should be revised to include information warning women that there is an increased risk of developing blood clots in the legs and lungs and the blood clots could be fatal. This followed the expe
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 308
- Bankruptcy 44
- Business 133
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4